A detailed history of Greenleaf Trust transactions in Insulet Corp stock. As of the latest transaction made, Greenleaf Trust holds 1,810 shares of PODD stock, worth $501,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,810
Previous 1,783 1.51%
Holding current value
$501,569
Previous $414,000 14.01%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$227.79 - $275.7 $6,150 - $7,443
27 Added 1.51%
1,810 $472,000
Q3 2024

Oct 22, 2024

BUY
$180.69 - $239.01 $13,009 - $17,208
72 Added 4.21%
1,783 $414,000
Q2 2024

Jul 22, 2024

BUY
$161.02 - $206.98 $275,505 - $354,142
1,711 New
1,711 $345,000
Q4 2023

Jan 31, 2024

BUY
$127.77 - $221.42 $162,395 - $281,424
1,271 New
1,271 $275,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.2B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.